ストックスクリーナーアプリを入手
44.04
1.22%
0.5456
前日終値:
$43.49
開ける：
$43.36
24時間の取引高:
1.25M
Relative Volume:
0.62
時価総額：
$8.29B
収益：
$550.17M
当期純損益:
$201.35M
株価収益率:
44.04
EPS:
1
ネットキャッシュフロー:
$232.07M
1週間 パフォーマンス:
+0.39%
1か月 パフォーマンス:
-8.29%
6か月 パフォーマンス:
-22.83%
1年 パフォーマンス:
-20.22%
1日の値動き範囲:
$43.28
$44.21
1週間の範囲:
$43.28
$46.65
52週間の値動き範囲:
$43.28
$85.21
Doximity Inc Stock (DOCS) Company Profile
名前
Doximity Inc
セクター
電話
(650) 549-4330
住所
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
44.03 | 8.19B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
224.34 | 35.85B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
64.25 | 11.07B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.82 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.61 | 6.61B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-10-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-10-10 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-10-01 | ダウングレード | Goldman | Neutral → Sell |
| 2025-07-09 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-06-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-02-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Neutral |
| 2024-11-14 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-09 | アップグレード | Needham | Hold → Buy |
| 2024-07-18 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2024-01-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-08-09 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-08-09 | ダウングレード | Needham | Buy → Hold |
| 2023-08-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 開始されました | Wells Fargo | Overweight |
| 2022-10-24 | 開始されました | Evercore ISI | In-line |
| 2022-10-13 | 開始されました | BTIG Research | Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 開始されました | Berenberg | Buy |
| 2022-05-18 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-18 | 繰り返されました | Goldman | Buy |
| 2022-05-18 | 繰り返されました | Guggenheim | Buy |
| 2022-05-18 | 繰り返されました | Jefferies | Buy |
| 2022-05-18 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 繰り返されました | Needham | Buy |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-04 | 開始されました | BofA Securities | Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-11-17 | 開始されました | Robert W. Baird | Outperform |
| 2021-11-10 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-11-10 | 繰り返されました | Goldman | Neutral |
| 2021-11-10 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 繰り返されました | Needham | Buy |
| 2021-11-10 | 繰り返されました | Piper Sandler | Overweight |
| 2021-08-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-19 | 開始されました | Goldman | Neutral |
| 2021-07-19 | 開始されました | JP Morgan | Overweight |
| 2021-07-19 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 開始されました | Piper Sandler | Overweight |
| 2021-07-19 | 開始されました | Raymond James | Outperform |
| 2021-07-19 | 開始されました | SVB Leerink | Outperform |
| 2021-07-19 | 開始されました | William Blair | Outperform |
すべてを表示
Doximity Inc (DOCS) 最新ニュース
Will Doximity Inc. stock outperform tech sector in 2025Forecast Cut & Short-Term High Return Ideas - Улправда
How Doximity Inc. stock compares to industry benchmarksWeekly Market Report & Technical Confirmation Alerts - DonanımHaber
How higher bond yields impact Doximity Inc. Class stockDollar Strength & High Accuracy Trade Alerts - DonanımHaber
How Doximity Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - DonanımHaber
How rising interest rates impact Doximity Inc. stockBond Market & Weekly Breakout Opportunity Watchlist - Улправда
Doximity (NASDAQ:DOCS) Hits New 12-Month LowShould You Sell? - MarketBeat
How Analyst Upgrades Highlighting AI Tools And Ad Shift Potential At Doximity (DOCS) Has Changed Its Investment Story - Yahoo! Finance Canada
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying By Investing.com - Investing.com South Africa
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends By Investing.com - Investing.com South Africa
Doximity stock hits 52-week low at 43.59 USD - Investing.com India
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying - Investing.com India
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends - Investing.com Nigeria
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event - Investing.com Nigeria
Texas Permanent School Fund Corp Acquires 82,274 Shares of Doximity, Inc. $DOCS - MarketBeat
How Doximity is looking to break through AI skepticism - Modern Healthcare
Doximity (DOCS) ascends while market falls: Some facts to note - MSN
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note - sharewise.com
Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook - Yahoo Finance
Doximity Sees Surge as AI Tools and Analyst Ratings Impress - StocksToTrade
Is Doximity Now an Opportunity After Recent Share Price Slide? - Yahoo Finance
Doximity rises after Morgan Stanley upgrades to 'overweight' - TradingView — Track All Markets
Doximity upgraded at Morgan Stanley on expanding market for HCP platforms - MSN
Doximity (NASDAQ:DOCS) Shares Gap UpStill a Buy? - MarketBeat
Doximity Offers Attractive Entry Point, Morgan Stanley Says - marketscreener.com
Doximity’s underperformance at odds with improving business, says MS - Investing.com
Morgan Stanley Upgrades Doximity to Overweight From Equalweight, Raises Price Target to $65 From $62 - marketscreener.com
Morgan Stanley upgrades Doximity stock to Overweight on conservative outlook - Investing.com Canada
Doximity (DOCS) Stock Trends and Sentiment 2025 - MarketBeat
Doximity, Inc. (NYSE:DOCS) Q2 2026 Earnings Call Transcript - MSN
Liontrust Investment Partners LLP Increases Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
AI Stocks: Will Doximity Inc stock keep outperforming rivals2025 Risk Factors & High Conviction Buy Zone Picks - moha.gov.vn
Published on: 2025-12-13 18:23:14 - moha.gov.vn
Healthcare AI Exits Pilot Phase, Enters Production Deployment - AI Magazine
Doximity director Yang Watkin Phoebe L. sells $217,209 in stock - MSN
Doximity (NASDAQ:DOCS) Reaches New 52-Week LowWhat's Next? - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Federated Hermes Inc. Has $11.47 Million Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Baird Financial Group Inc. Invests $4.14 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year! - Smartkarma
Barclays Initiates Coverage on Doximity (NASDAQ:DOCS) - MarketBeat
Natixis Grows Position in Doximity, Inc. $DOCS - MarketBeat
Invesco Ltd. Has $116.20 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Norges Bank Invests $6.21 Million in Doximity, Inc. $DOCS - MarketBeat
Prudential Financial Inc. Has $680,000 Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Holdings Cut by First Trust Advisors LP - MarketBeat
Is Doximity’s (DOCS) AI Surge Turning Workflow Tools Into Its Core Investment Story? - Sahm
Doximity (DOCS) Gains Overweight Rating from Barclays | DOCS Sto - GuruFocus
Rep. Jonathan L. Jackson Sells Doximity, Inc. (NASDAQ:DOCS) Shares - MarketBeat
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching - Yahoo Finance
Illinois Rep. Jonathan Jackson Sold Up to $80K Worth of Doximity Stock - Benzinga
Doximity Inc (DOCS) 財務データ
収益
当期純利益
現金流量
EPS
1.37%
1.17%
大文字化:
|
ボリューム (24 時間):